Description: Cardio Vascular Bio Therapeutics - CVBT is a biopharmaceutical company established to commercialize the breakthrough therapy developed by Dr. Thomas-Joseph Stegmann to treat coronary artery disease with a process known as angiogenesis. The treatment cons
Description: Its research is centered on the autologous human cells using a serum free medium to treat uncurable diseases. Cellular implants for regeneration of diseased tissues.